Genscript Biotech Corporation (1548.HK) HKSE

17.55

+1.04(+6.30%)

Updated at November 14 01:27PM

Currency In HKD

Valuation

Market Cap2.76B
Enterprise Value3.35B
P/E Ratio0.84
PEG Ratio0
Price/Sales Ratio8.73
Price/Book Ratio0.59
Enterprise/Revenue9.2
Enterprise/EBITDA12.78

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin5.64
Operating Margin0.61

Management Effectiveness

Return On Assets0.57
Return On Equity0.71

Income Statement

Revenue594.49M
Revenue/Share0.47
Gross Profit272.13M
EBITDA70.43M
Net Income2.96B
Diluted EPS-0.03

Balance Sheet

Total Cash938.36M
Total Cash/Share0.34
Total Debt548.52M
Total Debt/Equity0.12
Current Ratio1.96
Book Value Per Share3.75

Price History

52-Week Change57.51
52-Week High19.4
52-Week Low8.88
Moving Average 50 Days16.61
Moving Average 200 Days14.44

Statistics

Average Volume14M
Shares Outstanding2.18B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A